Elastin-like recombinamers with acquired functionalities for gene-delivery applications by Piña Lancho, María Jesús et al.
Elastin-like recombinamers with acquired functionalities for
gene-delivery applications
Maria J. Pi~naAQ3 ,1 Susan M. Alex,2 Francisco J. Arias,1 Mercedes Santos,1 Jose C. Rodriguez-Cabello,1
Rehka R. Mannemcherril,2 Chandra P. Sharma2
1Bioforge Research Group, University of Valladolid, CIBER-BBN, Valladolid 47011, Spain
2Biosurface Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology,
Poojappura, Thiruvananthapuram, Kerala 695 012, India
Received 18 December 2014; revised 26 February 2015; accepted 10 March 2015
Published online 00 Month 2015 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/jbm.a.35455
Abstract: In this work, well-defined elastin-like recombinamers
(ELRs) were studied as a choice to the existing nonviral vectors
due to their biocompatibility and ease of scale-up. Functional
motifs, namely penetratin and LAEL fusogenic peptides were
incorporated into a basic ELR sequence, and imidazole groups
were subsequently covalently bound obtaining ELRs with new
functionalities. Stable polyplexes composed of plasmid DNA
and ELRs were formed. A particle size around 200 nm and a
zeta potential up to nearly 124 mV made them suitable for
gene delivery purposes. Additionally, viability and transfection
assays with C6 rat glioma cell line showed an increase in the
cellular uptake and transfection levels for the construction con-
taining the LAEL motif. This study highlights the importance of
controlling the polymer functionality using recombinant techni-
ques and establishes the utility of ELRs as biocompatible non-
viral systems for gene-therapy applications. VC 2015 Wiley
Periodicals, Inc. J Biomed Mater Res Part A: 00A:000–000, 2015.
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INTRODUCTION
The importance of gene therapy is directly reﬂected by the
increasing number of clinical trials conducted over the past
few years.1 A large number of diseases, including some can-
cers, monogenetic disorders, and cardiovascular, neurologi-
cal and immune diseases, amongst others, are increasingly
being seen as possible targets for gene-therapy studies.2–4
The success of gene-therapy treatment depends on both the
genetic material concerned and on the carrier. Naked DNA
molecules cannot pass through the cell membrane due to its
negative charge; in addition, they are rapidly degraded
because of their high susceptibility to nucleases.5 As such,
vectors are a critical element in the gene-delivery process.
The most important attributes for the “ideal” delivery vector
are biocompatibility and an ability to release the cargo into
a speciﬁc target. In this regard, a great deal of research
effort has been focused on viral vectors, especially retro-
and adenoviruses. However, the inﬂammatory response in
the receptor organism and complications when scaling up
production make nonviral vectors an excellent alterna-
tive.6–9 Although nonviral vectors, such as cationic polymers,
exhibit lower transfection efﬁciency than viral vectors, they
present some advantages, namely that they generally have
low host immunogenicity, which would allow repeated
administration, and are easier to produce on a large scale.10
Cationic polymers are preferred due to their ability to con-
dense DNA by electrostatic interactions with the negatively
charged phosphates from the genetic material. This results
in a tight DNA-polymer complex, also known as a polyplex,
which protects the contents from degradation by the
enzyme nuclease.11
The extra- and intracellular obstacles that DNA-polymer
complexes encounter on their way to the target must be
taken into account when designing a gene-delivery system.
Firstly, anatomical barriers and subsequently the plasma
membrane are some of the most limiting steps in transfec-
tion. Molecules with a positive surface charge, such as cati-
onic polymers, tend to interact better with the plasma
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membrane.12 In addition to the surface charge of the macro-
molecule, size is another parameter that must be kept in
mind. Particles with a size smaller than 1 mm tend to be
internalized by phagocytosis and those of around 200 nm
by endocytic processes.13 Furthermore, rather than the sur-
face charge, other systems, such as certain arginine-rich
peptides, exhibit high efﬁcacy in the internalization pro-
cess.14,15 Molecules that enter via the endocytosis pathway
experience a drop in pH from physiological to pH 6, with
subsequent further reduction to pH 5 during progression
from late endosomes to lysosomes and the presence of lytic
enzymes. Some escape mechanisms have been studied to
release complexes from the endosome. One such approach
involves the use of fusogenic molecules in order to disrupt
the endosome membrane,16 whereas another involves the
use of weak amine groups such as imidazole with an effect
similar to the cationic polymer PEI (polyethyleneimine). PEI
acts on the osmotic pressure within the endosome, causing
the vesicle to rupture as a result of the called “proton
sponge effect.” When the complexes formed by these com-
pounds and nucleic acids are internalized into the cell, they
are able to buffer the endosomal vesicle, leading to endoso-
mal swelling and lysis, thus releasing the nucleic acids into
the cytoplasm.10,17,18 However, the main problem of PEI is
its cytotoxicity, causing cell apoptosis in a wide number of
human cell lines.19 The cytocompatibility nature of the
material forming the polyplexes and their ability to over-
come these natural barriers will therefore determine the
success of the system.20,21
Elastin-like recombinamers (ELRs) are polymers with
increasing applications in different ﬁelds, such as tissue
engineering, protein puriﬁcation, cell harvesting, and smart
and bioactive surfaces.22–24 These compounds are based on
the hydrophobic domain of natural elastin, which is one of
the main components of the extracellular matrix. They are
composed of repetitions of the pentapeptide (Val-Pro-Gly-X-
Gly), or its permutations, where X is a guest residue that
can be any amino acid except proline. The smart nature of
ELRs resides in their characteristic transition temperature
(Tt). Below this temperature, the ELR chains are hydro-
phobically hydrated, forming a disordered state of random
coils, whereas above Tt the structure loses its water mole-
cules to form a phase-separated state in which the ELRs
adopt a dynamic, regular, and ordered b-spiral structure,25
thereby resulting in a variation in enthalpy. This folding is
reversible if the temperature is decreased below Tt.
25 The
similarity with native elastin endows ELRs with biocompati-
bility, smart behavior, and excellent mechanical properties.
The biocompatibility of such compounds has been tested by
the ASTM (American Section of the International Association
for Testing Materials) and conﬁrmed in numerous other
studies.26 Recent studies have suggested that ELRs are
promising materials for delivery purposes27 by demonstrat-
ing the use of ELRs fused to a cell penetrating peptide
(CPP) as a drug delivery vector for solid tumors.16,17,28
Additionally, a similar combination of ELRs fused to CPPs
has been utilized to deliver therapeutic peptides into target
tumor cells.29
We hypothesized that, given the properties of ELRs, the
lysine-based vector with the sequence ((VPGIG)2(VPGKG)
(VPGIG)2) 324 modiﬁed with different functional motifs
namely penetratin, the fusogenic peptide LAEL and imidaz-
ole addition is able to improve the delivery of genetic mate-
rial inside the cells tested in in vitro assays with low
cytotoxicity.
MATERIALS AND METHODS
ELR biosynthesis and characterization
Standard molecular-biology techniques were used to create
the polymers IK120, IK120CPP, and LAELIK120CPP.23 ELRs
were based on the Val-Pro-Gly-Xaa-Gly (VPGXG) structure,
where X is isoleucine or lysine: ((VPGIG)2(VPGKG)(VPGIG)2)
324 and containing the bioactive CPP (RQI-
KIWFQNRRMKWKK) and LAELLAELLAEL domains. Addition
of the monomeric genes was accomplished in a stepwise
manner using the recursive directional ligation method, and
polymers with a speciﬁc length and molecular weight were
produced as described elsewhere.30
A chemical amidation reaction was applied during the
synthesis of IMID-IK120 in order to incorporate imidazole
groups into the IK120 lysine-enriched amino acid sequence.
The ELR sequences were transformed into Escherichia
coli BLR (DE3) strain (Stratagene, La Jolla, CA) for produc-
tion. The puriﬁcation process involved cycles of temperature-
dependent and reversible precipitation.31 Endotoxins were
removed using an additional NaCl and NaOH treatment.32
All polymers were characterized by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), mass
spectrometry (MALDI-TOF), proton nuclear magnetic reso-
nance analysis (H-NMR), differential scanning calorimetry
(DSC), and amino acid analysis. Endotoxin levels were meas-
ured using the Endosafe-PTSTM test (Charles River, Wil-
mington, MA).
Synthesis of IMID-ik120
Imidazole functional groups were conjugated to the lysine
amino acids in IK120 as follows.
A solution of NHS (12 equiv.) in MES (2-(N-morpholi-
no)ethanesulfonic acid buffer) was added to a solution of
EDAC (1-ethyl-3-(dimethylaminopropyl) (Sigma Aldrich, St.
Louis, MO) (12 equiv.) in MES at pH 4.5. EDAC acts as an
activating agent for the carboxyl group. The resulting mix-
ture was stirred at 4 C for 1 h and a solution of 1-H-imid-
azole-2-carboxylic acid (10 equiv.) in MES buffer was then
added. This mixture was stirred at 4 C for 1 h. After this
time, a freshly prepared solution of IK120 ELR (1 equiv.) in
MES was added and the reaction mixture stirred at 25 C
for 72 h. The IMID-IK120 obtained was diluted in deionized
water, dialyzed and lyophilized. Incorporation of the imidaz-
ole groups was corroborated by DSC and H-NMR.
Thermal behavior
All the ELR polymers were dissolved in PBS 13 (Sigma
Aldrich, St. Louis, MO) at 50 mg/mL at 4 C 24 h before of
the measurement. Thermal behavior was accomplished by
DSC using a Mettler Toledo 822e with liquid-nitrogen cooler.
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The heating program included an initial isothermal stage (5
min at 0 C), followed by heating at 5 C/min from 0 C to
the desired temperature of around 55 C.
To assess the incorporation of the imidazole groups in
IMID-IK120, the polymer was dissolved at 50 mg/mL in
deionized water for 24 h at 4 C and adjusted to pH 10.7,
8.0, and 3.5 with NaOH 1M and HCl 1M. Consecutive meas-
urements were accomplished at pH 10.7, 8.0, and 3.5with
the previously described method.
Buffering capacity
The buffering capacities of ELRs were measured as follows.
A 2.5 mg sample of the ELR was dissolved in 25 mL of
0.9% NaCl to a ﬁnal concentration of 0.1 mg/mL and stored
at 4 C overnight. The initial pH of the polymer solution
was adjusted to 10 with 0.2N NaOH and titrated by gradual
addition of 50 mL aliquots of 0.01N HCl. The pH values for
all solutions were measured using a pH-meter (Crison
GLP22). PEI 25 kDa (Sigma Aldrich, St. Louis, MO) was used
as control.
Hemocompatibility studies
Hemocompatibility studies were performed with blood from
non-medicated healthy human donors and collected in tubes
containing 3.8% sodium citrate at a 9:1 (blood:anticoagu-
lant) ratio. IK120, IMID-IK120, IK120CPP, and LAE-
LIK120CPP were dissolved in 0.9% NaCl at a concentration
of 1 mg/mL. For each assay, 100 lg of ELR was required.
Red blood cell (RBC) aggregation. After centrifugation of
the anticoagulated blood at 700 rpm for 10 min, the plasma
and red blood cell fraction were separated. The RBC fraction
was diluted in 0.1M PBS pH 7.4 (8:1); 100 lL of red blood
cells was incubated for 30 min with 100 lL of ELR solution
or PEI (1 mg/mL). PEI 25 kDa was used as positive control
and 0.9% NaCl as negative control.
White blood cell (WBC) and platelet blood cell (PBC)
aggregation. For separation of WBC and platelets, blood
was layered over an equal amount of Histopaque 1077
(Sigma Aldrich, St. Louis, MO) in clean glass tubes. Centrifu-
gation was carried out at 800 rpm for 15 min to obtain the
upper yellow (platelet blood cells) and middle white blood
cells. White blood and platelet cells were incubated with
100 mg of ELR or PEI for 30 min.
The aggregation results were observed under a Leica
DF295 microscope.
Cell culture
In vitro and transfection experiments were performed using
the C6 glioma cell line from rat (ATCCVR CCL-107, ATCC,
Middlesex, UK). C6 cells were chosen as it has been widely
used as suitable gene therapy host in glioblastoma
research.33–35 Cells were seeded in culture ﬂasks with
DMEM medium in 10% FBS and incubated at 37 C for
24 h in 5% CO2 with 95% humidity to obtain a growth con-
ﬂuence of 80%. Cells were then trypsinized and transferred
to multiwell tissue culture plates.
In vitro viability assay of ELRs
The cell viability of IK120-based ELRs was evaluated using
the Alamar Blue and Live/Dead assays (Life Technologies,
Carslbad, CA) on C6 cells. Cells were seeded on 96-well
plates at 5000 cells/cm2 in 100 mL DMEM medium with
10% FBS for 24 h. After that time, the medium was dis-
carded and cells were incubated for 24 h with 5 mL ELR dis-
solved at different concentrations and made up to 100 mL
with FBS-free medium. For the Alamar Blue assay, the poly-
mers were removed after 24 h and 100 mL Alamar Blue
solution was added to each well to a ﬁnal concentration of
1%. PEI at 20 mg/mL was used as reference polymer.
Untreated cells were considered to calculate the % cell via-
bility. The ﬂuorescence intensity (F.I.) of test samples and
controls was measured at an emission wavelength of
590 nm after excitation at 560 nm using a SpectraMax M2
microplate reader (Molecular Devices, Sunnyvale, CA,). Cell
viability was calculated as:
% Cell viability ¼ 1003 ðF:I: Treated cells=
F:I: Untreated cellsÞ
For the Live/Dead assay, after removing the polymers,
50 mL each of a solution of calcein AM and ethidium
homodimer-1 were added to each well at a ﬁnal concentra-
tion of 2 lM and 4 lM in D-PBS, respectively. The plate was
then incubated in the dark at room temperature for 30 min
and visualized under a ﬂuorescence microscope (Nikon
eclipse Ti-SR, Japan).
Preparation of ELR complexes
Cationic ELR-based polymers underwent rapid complex for-
mation with the negatively charged plasmid DNA. Thus, the
ELR was dissolved to a concentration of 1 mg/mL in deion-
ized water at 4 C overnight. Plasmid DNA was also pre-
pared with the same concentration of 1 mg/mL.
Nanoparticles were formed in aqueous solution by mixing
the pDNA with the ELR solution at the appropriate weight
ratio. The mixtures were vortexed at 10 C for 1 min and
incubated at 4 C for 20 min for nanocomplex formation.
After this incubation the temperature was increased to 37
C for immediate application.
Gel retardation assay
The ELR-pDNA complexes at different pDNA/ELR weight
ratios (10/1, 40/1, 80/1, 120/1, and 140/1) were loaded
onto a 1% agarose gel. Electrophoresis was carried out in
13 TBE buffer (89 mM Tris-HCl pH 8.3, 89 mM borate, and
2 mM EDTA), staining with 2 mL of 10 mg/mL ethidium bro-
mide. Electrophoresis was run at room temperature at 100
mV for 60 min in a Bio-Rad electrophoresis device (Bio-Rad
laboratories, CA). The complexed pDNA was visualized and
photographed using a MultiImage TM Light Cabinet (Alpha
Innotech Corporation, San Leandro, CA).
Stability assay
For the stability assay, nanocomplex formation at ELR/
pDNA weight ratios of 10/1, 40/1, 80/1, 120/1, and 140/1
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was performed. The resulting nanocomplexes were incu-
bated with 20 mL of plasma, from nonmedicated healthy
human donors, for 30 min.36 The displacement was
detected by 1% agarose gel electrophoresis and visualized
using a MultiImage TM Light Cabinet (Alpha Innotech Cor-
poration, San Leandro, CA).
Determination of particle size and zeta potential
The particle size and zeta potential of the nanocomplexes
were determined by Dynamic Light Scattering (DLS) using a
Zetasizer Nano ZS (Malvern Instruments Ltd., UK) at a tem-
perature of 15 C for 40/1, 80/1, 120/1, and 140/1 ratios.
Z-average mean (nm) and zeta potential (mV) were used for
data analysis.
Tranmission electron microscopy
TEM measurements were performed using a JEOL JEM-1230
electron microscope operating at 120 kV. The polyplex solu-
tion of ELR and pDNA was dropped onto carbon-coated cop-
per grids and images recorded after drying for 5 min at
room temperature.
Cell-transfection studies
P53 expression. C6 cells were seeded into four-well plates
in a quantity of 1 3 104 per well and allowed to grow at
37 C under 5% CO2 overnight.
ELRs and pCMV-p53 plasmid (Clontech, CA) were used
to form nanocomplexes at two different ELR:pDNA weight
ratios (80/1 and 120/1). The cells were incubated with the
nanocomplexes at 37 C under 5% CO2 for 5 h. After this
time, the medium was replaced with fresh medium and the
cells incubated for a total of 48 h. Before the assay, the cells
were washed twice with PBS. A 250 mL aliquot of calcein
AM ethidium homodimer-1 reagent solution was added and
the mixture left in the dark at room temperature for 30
min. After this time, the reagent was discarded and 400 mL
PBS added. The state of the cells was visualized using a ﬂu-
orescence microscope (Leica DMI 3000 B, Germany).
Polyplex cell internalization. A total of 1 3 104 C6 cells
per well were seeded onto four-well plates and allowed to
grow overnight at 37 C under 5% CO2. p53 plasmid was
tagged with YOYO iodide by incubation for 1 h in the dark.
ELR/pDNA nanocomplexes were prepared at a ratio of 80/1
and the cells incubated for 3 h with these complexes.
Nuclear staining was performed using Hoechst by incuba-
tion at 37 C under 5% CO2 for 30 min. The cells were then
washed with PBS and viewed under the ﬂuorescence
microscope.
Luciferase expression. A total of 3.5 3 104 C6 cells per
well were seeded onto 96-well plates and grown at 37 C
under 5% CO2 overnight. After this time the cells were incu-
bated with the polyplexes (80/1 weight ratio) formed with
a plasmid containing the luciferase gene (pRNA-Luc/Neo,
GenScript, Piscataway, NJ) in a serum-free medium for 5 h.
The medium was then replaced by fresh serum-containing
medium and the cells cultured for a further 48 h. At this
point the cells were lysed with 100 lL Glo lysis buffer
(Promega). The Bright Glo luciferase assay system (Prom-
ega) was added in a 1:1 proportion of lysate and luciferase
reagent. The light produced was measured using a lumi-
nometer (SpectraMax L, Molecular Devices). The protein
content of the lysate was determined by a Bradford assay
using a microplate reader. Luciferase expression is given as
relative light units (RLU) per mg of protein.
Statistical analysis
Inter-group comparisons were performed using Scheffe’s
test, with p values of less than 0.05 indicating statistical
signiﬁcance.
RESULTS
Synthesis and characterization of IK120CPP,
LAELIK120CPP, and IMID-ik120
The ELRs were designed using an existing ELR cationic
backbone in order to condense the plasmid DNA and inter-
act with the negatively charged plasmatic membrane. Novel
ELRs containing the bioactive domains CPP (RQI-
KIWFQNRRMKWKK) and LAEL (LAELLAELLAEL) were syn-
thesized using genetic-engineering techniques. The bioactive
domains were introduced by recursive directional ligation
(RDL), which allows full control of the composition, chain
length, architecture and physicochemical properties of the
ELRs and therefore giving them an advantage with respect
to other polymers30 (Fig. F11). The yields for these polymers
in Escherichia coli were 35 and 50 mg/L, respectively
(Table T1I). The decrease in the yield for IKCPP was attributed
to destabilization of the bacterial membrane by CPP. The
polymer IMID-IK120 was constructed by chemical incorpo-
ration of imidazole 2-carboxylic acid into the IK120 cationic
backbone (Supporting Information Fig. S1). Schematic con-
structs for all polymers studied can be found in Figure 1.
The ﬁnal products were characterized by SDS-PAGE elec-
trophoresis (data not shown), mass spectrometry (MALDI-
TOF), nuclear magnetic resonance (H-RMN), differential
scanning calorimetry (DSC), and amino acid analysis (Sup-
porting Information Figs. S2–S5). The endotoxin levels were
<50 EU/mg.
Thermal behavior of the ELRs
The smart nature of the polymers was studied by DSC with
the polymers dissolved in PBS (Table T2II). They were found
to behave as self-assembled systems with a transition tem-
perature (Tt) of around 30 C, which would permit their use
at an optimal temperature of 37 C for gene-delivery appli-
cations. All the ELRs in this study varied their enthalpies,
thus resulting in endothermic processes.
A deeper study of the thermal behavior for the IMID-
IK120, was conducted (Fig. F22 and Supporting Information
Table S1). As such, the Tt increased as the polarity increased
with decreasing pH. Indeed, at pH 10.7 basiﬁcation of the
medium is sufﬁciently high that the amino groups of the
lysines (pKa 10.5) from the polymer are largely deproto-
nated. This reduces the mean polarity of the molecule,
thereby producing a decrease in Tt to 18.5 C. Moreover, as
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the pKa of the imidazole is around 6.9, this group is depro-
tonated above pH 7, thereby intensifying the reduction of
Tt. However, the variation in Tt at a pH of between 10.7 and
8.0 (22.6 C) indicated that not all the lysines had been
modiﬁed with imidazole groups and that their amino groups
had therefore been protonated. The NMR spectra showed
signals at 7.7 ppm corresponding to H-N1 and H-C5 protons
from imidazole. Moreover, the CH2 group vicinal to the
amide groups appeared at 2.9 ppm. Integration of the peaks
led to a substitution percentage of 65% (Supporting Infor-
mation Fig. S4). Finally, a signiﬁcant increase of 10 C in Tt
was observed at pH 3.5 (32.4 C) as a result of protonation
of the imidazole groups.
Buffering capacity
To evaluate the protonation ability of ELRs in general and
imidazole groups for IMID-IK120 in particular, both ELRs
and PEI as reference polymer were titrated against 0.01N
HCl from pH 10.0 to pH 4.0.
Our ﬁndings showed that PEI polymer possessed larger
buffering effect than ELRs especially at physiological pH (7–
5). However, at these concentrations, IMID-IK120 showed a
milder increase in buffering capacity in the pH range 8 to 6
than the other ELRs, thereby correlating with protonation of
the imidazole groups (Fig.F3 3).
Blood compatibility assays
Blood cell aggregation studies with the red blood cell frac-
tion (Fig.F4 4), white cells and platelets (Supporting Informa-
tion Figs. S6 and S7) were carried out. The results showed
no aggregation with any of the blood cells in the ELR-
treated samples. In contrast, the PEI polymer alone
appeared to trigger marked aggregation processes at the
same ﬁnal concentration of 0.5 mg/mL.
With regard to the interaction between the polymers
and the main protein components of plasma (IgM, ﬁbrino-
gen, transferrin, and albumin), the electrophoresis patterns
showed no interaction with the ELRs, whereas PEI induced
the complete absence of ﬁbrinogen and partial reduction in
the other bands (Supporting Information Fig. S8). Accord-
ingly, these results demonstrate that the ELRs studied
herein are more compatible with blood components than
PEI.
Cell viability
The effect of the ELRs on cellular viability was tested in the
adherent C6 glial tumoral cells. The ﬁndings [Fig. F55(A)]
showed that the viability of cells incubated with ELRs was
clearly higher than 100%, even at the highest concentration
studied (450 mg/mL), and about 150% at a concentration of
100 mg/mL. The quantitative results were visually con-
ﬁrmed by way of the Live and Dead assay images, as shown
in Fig. 5(B), where green (live) cells are predominant. Simi-
lar results were obtained with mesenchymal stem cells
(data not shown). In contrast, highly cytotoxic effects of PEI
were found [Fig. 5(A)]. The present ELRs, appear to be bio-
compatible toward both cultured adherent cells at high con-
centration and blood components.
DNA condensation ability and plasma-release assays
ELR-pDNA polyplexes were prepared at the speciﬁc (ELR)/
(pDNA) weight ratios (from 10/1 to 140/1) and their com-
plexation was evaluated in a gel-retardation experiment
(Fig. F66). The strong interaction of these polymers with DNA
reduces the mobility of the latter in the agarose gel.
IK120CPP was the best polymer in terms of condensing
FIGURE 1. Schematic representation of the ELR constructs. [Color figure can be viewed in the online issue, which is available at wileyonlineli-
brary.com.]AQ4
TABLE I. Results of MALDI-TOF Analysis and Final Polymer
Production Yields
Experimental MW
(Da) (Mean6SD)
Yield
(mg/L)
IK120 51,9966 11.3 154
IMID-IK120 54,6176 7.9 65%a
IK120CPP 54,3196 4.3 35
LAELIK120CPP 55,6966 2.8 50
TABLE II. Transition Temperature (Tt) and Enthalpy Change
for the ELRs
Tt (
C) DH (Jg21)
IK120 27.2 26.8
IMID-IK120 22.1 22.1
IK120CPP 31.3 24.8
LAELIK120CPP 27.0 24.1
J_ID: JBM Customer A_ID: JBMA35455 Cadmus Art: JBMA35455 Ed. Ref. No.: JBMR-A-14-1084.R1 Date: 20-March-15 Stage: Page: 5
ID: nagarajulum Time: 12:57 I Path: N:/3b2/JBMM/Vol00000/150060/APPFile/JW-JBMM150060
ORIGINAL ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | MONTH 2015 VOL 00A, ISSUE 00 5
pDNA from 10/1 ratio. In contrast, LAELIK120CPP com-
plexed pDNA better from 40/1 ratio and IMID-IK120 lost
the pDNA at all the ratios tested.
Additionally, the stability of the nanocomplexes at differ-
ent ratios when incubated with plasma was studied (Sup-
porting Information Fig. S9). The data showed that the
plasma altered the mobility of pDNA alone, retaining it in
the well. Plasma components were able to compete with
pDNA for polymer binding and displace it at a ratio of 10/1.
The weak ability of IMID-IK120 polyplexes to condense
pDNA was clariﬁed, as shown by the fact that the strongest
band appears at a 10/1 ratio. However, the ELR-pDNA inter-
action was sufﬁciently strong at ratios of 40/1 and higher;
therefore ratios from 40/1 to 120/1 were chosen for physi-
cal characterization of the polyplexes.
Determination of particle size and z-potential
Size measurements showed the formation of ELR-pDNA pol-
yplexes triggered by the presence of pDNA, which con-
denses and promotes ELR complexation and self-assembly.
The particle-size distribution for the resulting ELR-pDNA
polyplexes varied from 150.0 to 309.4 nm (Table T3III). For
IK120 and IMID-IK120, the particle size mainly decreased
at high ratios. In contrast, the particle size for IK120CPP
and LAELIK120CPP increased with amount of polymer
(Table III). The formation of spherical nanoparticles was
corroborated by TEM microscopy. All polyplexes showed a
rounded shape and no major differences were observed
between the ELRs (Fig. F77), with particle sizes being similar
to those obtained with the DLS.
The resulting z-potential of the ELR-pDNA polyplexes
ranged from 111.4 to 123.5 mV and are summarized in
FIGURE 3. Buffering capacity of the ELRs compared with PEI 25 kDa
in 0.9% NaCl solution. The x-axis is plotted in logarithmic scale to
facilitate visualization of the data. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
FIGURE 2. DSC for IMID-IK120 at different pH and at a concentration
of 50 mg/mL in deionized water.
FIGURE 4. Aggregation studies of the red blood cell fraction with 0.5 mg/mL ELRs. Saline was used as negative control and 0.5 mg/mL PEI as
control.
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TableT4 IV. The increase in z-potential value was found to be
correlated with an increase in the amount of polymer at the
140/1 ratio. Speciﬁcally IMID-IK120 showed a lower zeta
potential than IK120 at ratios of 40/1 and 80/1 due to sub-
stitution of the lysines, although both values were similar at
higher ratios. The highest zeta potential was found for
IK120CPP and LAELIK120CPP, both of which had a value of
more than 120 mV due to the presence of arginine-
enriched CPP, which provides more positive charge to the
system.
Cell transfection and trafﬁcking assays
In light of the previous assays, ELR-pDNA weight ratios of
80/1 and 120/1 showed the best physical features, namely
a particle diameter around 200 nm and a zeta potential up
to nearly 124 mV with high cell viability, for testing as
ELR-based gene-delivery systems in vitro. Expression and
localization of the genetic material transfected into the cells
was determined by confocal ﬂuorescence and quantiﬁed
using the luciferase assay.
P53 expression. C6 glioma cells were selected as standard
as this cell line is widely used for transfection, especially in
glioblastoma research.33–35 Plasmid DNA containing the p53
transgene was used to evaluate gene expression with ELRs
as vectors over a prolonged time period (48 h). Successful
delivery of the transgene into the nucleus was determined
by the activation of apoptosis, as p53 gene expression is
known to lead to cell death.37 With this assay, signiﬁcant
death was observed for cells treated with all the different
polyplexes formed with functionalized IK120 ELRs. How-
ever, the death effect was visibly higher in cells treated with
polyplexes containing LAELIK120CPP at ratios of 80/1 and
120/1 in comparison with IK120 polyplexes and untreated
control cells (Fig. F88). Nevertheless, there was no signiﬁcant
difference between the 80/1 and 120/1 ratios.
Polyplex cell internalization. The localization of the poly-
plexes once transfected into C6 cells was evaluated using a
confocal ﬂuorescence microscope. The selected ratio for this
test was 80/1 ratio as this gave together with 120/1 the
FIGURE 5. A. Cell viability of C6 cells incubated with ELRs at different concentrations, with PEI as reference polymer and BSA as negative and
positive control, respectively. Cells were incubated with the polymer solutions for 24 h. Results are expressed as mean6 standard error (SE). B.
Live/Dead assay for C6 cells incubated with 200 mg/mL IKCPP for 24 h. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 6. Agarose gel electrophoresis retardation assay at different ELR-pDNA (w/w) ratios. Polymer-free pDNA was used as control.
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qualitative highest p53 expression for the IK120 modiﬁed
polymers (Fig.F9 9). To this end, pDNA containing the p53
transgene was tagged with YOYO (green) and the nucleus
stained with Hoechst (blue). A wide distribution of the plas-
mid in the cytoplasm and nucleus could be appreciated
from the samples incubated with polyplexes (Fig. 9) at the
selected weight ratio of 80/1. After 3 h of incubation with
cells, the plasmid containing the p53 gene appeared in both
the cytoplasm and the nucleus when complexed with IMID-
IK120 and IK120CPP. In contrast, the plasmid carried by
LAELIK120CPP was mainly located in the cytoplasm.
Luciferase transfection and expression. The quantiﬁcation
of transfection by the polyplexes was accomplished using
the luciferase assay. Luciferase expression in the cells
treated with the ELR polyplexes showed signiﬁcantly better
results in comparison with the plasmid alone (Fig.F10 10). Spe-
ciﬁcally, polyplexes containing the LAELIK120CPP polymer
exhibited more than ﬁvefold higher luciferase expression
than pDNA and more than twofold when comparing with
the non-functionalized IK120. These results highlight the
increasing improvement of transfection by incorporation of
both penetratin and especially LAEL peptide into the lysine
rich ELR construct.
DISCUSSION
Delivering efﬁciently genetic material into the cells by the
use of nontoxic nonviral vectors is a bottleneck in the
design of new gene delivery systems. For this purpose ELRs
with biofunctional domains were developed by genetic engi-
neering techniques allowing the full control over their com-
position and positioning them as an excellent alternative to
other existing polymers. In the present study a lysine-based
ELR was modiﬁed with several motifs in order to improve
the delivery of genetic material inside the cells with low
cytotoxicity. As a result, two main strategies were adopted.
The ﬁrst strategy involved improving entry into the cell by
designing an ELR with a bio-functional penetratin CPP
domain derived from the Antennapedia transcription factor
from Drosophila melanogaster. This is an amphiphilic pep-
tide rich in arginines, with a positive charge at physiological
pH, that is able to cross the cell membrane and enter the
cytoplasm, thereby promoting the internalization of oligonu-
cleotides, peptides and nanoparticles.38 Penetratin was
selected as the CPP of choice due to its high transfection
efﬁciency and nontoxicity when complexed with ELRs.29
When the polymeric vector enters the cell via the endocytic
pathway, it is encapsulated in an endosome vesicle and
therefore experiences a drop in pH from the physiological
value to pH 6 in the endosome and pH 5 inside the lyso-
some.13 The polymer and its DNA cargo would presumably
be degraded by lysosomal enzymes. The second strategy
involved stimulating endosome escape by two alternatives,
namely recombinant incorporation of the fusogenic peptide
“LAEL”39 into the basic ELR sequence and chemical addition
of imidazole functional groups with buffering capacity into
the basic ELR polymer. As described in the literature, LAEL
undergoes a structural change when the pH drops from
physiological values to 5.0,39 changing from a random coil
to a-helix, thereby resulting in destabilization of the endo-
some membrane. In contrast, the modiﬁcation with imidaz-
ole groups (pKa of 6.9) favors disruption of the endosome
supported by the proton sponge hypothesis.10 The protona-
tion of imidazole at endosomal pH (pH 6) triggers an inﬂux
of water and ions, thereby destabilizing and disrupting the
endosome. This strategy would improve the buffering
capacity of the polymer and facilitate release of the poly-
mer/pDNA complex into the cytoplasm.17,40 The expected
FIGURE 7. TEM images for polyplexes IK120CPP-pDNA (left side) and LAELIK120CPP-pDNA (right side). Both with a 0.2 lm bar scale.
TABLE III. Particle Size (z-Average nm) for the ELR-pDNA Plasmid Nanocomplexes at Different Weight Ratios (Mean6SD) in
Deionized Water
ELR/pDNA Ratio (w/w) IK120 IMID-IK120 IK120CPP LAELIK120CPP
40/1 292.16 6.2 179.16 4.1 171.961.2 155.76 2.2
80/1 272.76 5.9 190.06 4.0 175.168.3 159.66 1.7
120/1 173.06 0.9 150.06 1.8 246.567.7 159.86 2.1
140/1 229.26 8.3 165.06 9.6 309.4610.0 177.16 3.9
J_ID: JBM Customer A_ID: JBMA35455 Cadmus Art: JBMA35455 Ed. Ref. No.: JBMR-A-14-1084.R1 Date: 20-March-15 Stage: Page: 8
ID: nagarajulum Time: 12:58 I Path: N:/3b2/JBMM/Vol00000/150060/APPFile/JW-JBMM150060
8 PI~NA ET AL. ELRS AS BIOCOMPATIBLE NONVIRAL SYSTEMS FOR GENE-THERAPY APPLICATIONSAQ1
behavior of the imidazole groups by the aforementioned
proton sponge mechanism was assessed by the variation in
the IMID-IK120 polarity at the different pH as shown in Fig-
ure 2 and Supporting Information Table S1 and by the
increase in the buffering capacity of the polymer at pH
range 8 to 6 in comparison with the others ELRs. Accord-
ingly, modiﬁcation of IK120 with imidazole functional
groups at 65% substitution results in an increase in the
proton-capturing tendency of the polymer.
The next step was to evaluate the biocompatibility of
the ELRs. Although the ELR/pDNA nanocomplex has to be
positively charged in order to interact with the cell mem-
brane and ensure transfection, some aggregation processes
with blood components may appear if this positive charge is
too high, thus causing problems of cell lysis and clotting.41
As such, the biocompatibility of ELRs with blood cells and
plasma was addressed to ensure that the physiological ﬂuid
system of our body is able to tolerate the impact of the
polymers, which is a prerequisite for gene-therapy applica-
tions. Blood cell aggregation studies (Fig. 4) showed no
aggregation with any of the blood components in compari-
son with the striking aggregation process existing in the PEI
treated samples. Additionally, the effect of the ELRs on cel-
lular viability was tested in the adherent C6 glial tumoral
cells. Our ﬁndings [Fig. 5(A)] showed that the viability of
cells incubated with ELRs was clearly higher than 100%,
even at the highest concentration studied (450 mg/mL), and
about 150% at a concentration of 100 mg/mL. Similar viabil-
ity levels over 100% had been previously obtained on
mouse myoblastoma cell line,42,43 in human breast cancer
cell line44 and mesenchymal stem cell42,45 when cells were
incubated with ELRs nano/microparticles, thereby demon-
strating the innocuous behavior of these polymers.46 The
quantitative results were visually conﬁrmed by way of the
Live and Dead assay images, as shown in Figure 5(B), where
green (live) cells are predominant. Similar results were
obtained with mesenchymal stem cells (data not shown). In
contrast, highly cytotoxic effects of PEI were found [Fig.
5(A)], which had been previously reported for the C6 gli-
oma cell line47 and in 293T from human kidney above 4
mg/mL.48,49 PEI produces nonspeciﬁc cytotoxicity as a result
of destabilization of the plasmatic and mitochondrial mem-
branes, which triggers the activation of apoptotic pathways,
thereby restricting its clinical application.50–52 The present
ELRs, however, appear to be biocompatible toward both cul-
tured adherent cells at high concentration and blood com-
ponents, both of which are aspects that must be considered
when developing gene-therapy strategies.
ELR-pDNA polyplexes were prepared at speciﬁc (ELR)/
(pDNA) weight ratios. The condensation of DNA-forming
nanocomplexes is a critical step that inﬂuences their entry
into cells but also their stability and protection against
nucleases attack.53 In this case, the electrostatic interactions
between the amino groups from the polymer and the
TABLE IV. Zeta Potential (mV) for the ELR-pDNA Plasmid Nanocomplexes at Different Weight Ratios (Mean6SD)
ELP/pDNA Ratio (w/w) IK120 IMID-IK120 IK120CPP LAELIK120CPP
40/1 113.66 0.4 111.46 0.5 119.16 0.5 115.660.3
80/1 113.76 0.2 112.66 0.3 121.26 0.4 118.160.2
120/1 113.96 0.0 113.86 0.3 123.46 1.5 121.460.6
140/1 114.26 0.7 114.16 0.5 123.56 0.7 121.560.3
FIGURE 8. Live/Dead assay for C6 cells transfected with ELR-p53 plas-
mid and PEI-p53 plasmid polyplexes at different weight ratios. Live
cells are stained green and dead cells red. Cells visualized using an
inverted fluorescence microscope. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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negatively charged phosphate groups from the backbone of
the DNA allow this complexation, which was evaluated in a
gel-retardation experiment (Fig. 6). IK120CPP had the high-
est and IMID-IK120 polymer the lowest condensation ability
with the pDNA. The explanation for this ﬁnding for IMID-
IK120 lies in the fact that this polymer only contains 10
free lysines, with the remaining 15 being substituted by
imidazole groups, thus meaning that IMID-IK120 was less
able to condense pDNA than the non-modiﬁed polymer. In
addition, an appropriate stability of the resulting polyplex is
required in order to protect the genetic material during traf-
ﬁcking through the physiological environment. Charged
serum components, such as albumin, may destabilize the
polyplex by competitive binding or by cationic polymer dis-
placement.36 As shown in the Supporting Information Figure
S9, the obtained polyplexes were sufﬁciently stable espe-
cially for IK120CPP and LAELIK120CPP.
The resulting polyplexes showed a particle size from
150.0 to 309.4 nm (Table III). This range is appropriate for
cellular uptake, and particles of this size are thought to be
internalized mainly via clathrin-dependent or -independent
endocytosis phenomena.13,54 The size of polyplexes made of
synthetic polycations may be sensitive to kinetic factors as
concentration, temperature, or mixing speed.55,56 In our
study we showed that the presence of a sufﬁciently content
of ELR was necessary for the good stability of the poly-
plexes (Fig. 6 and Supporting Information Fig. S9). For this
reason we hypothesized that from (ELR)/(pDNA) weight
ratio of 40/1 the polyplexes were stable and the tempera-
ture change from mixing (10 C) to the application in vitro
(37 C) would not affect signiﬁcantly to their particle size.
Additionally, the mixing method used in this study guaran-
teed the homogeneous distribution of the ELR concentration
in the sample and showed the presence of homogeneous
particle size populations (Supporting Information Fig. S10).
In contrast the particle size was inﬂuenced by the concen-
tration of ELR. For IK120 and IMID-IK120, the particle size
mainly decreased at high ratios due to the ability of these
polymers to pack tightly. However, the particle size for
IK120CPP and LAELIK120CPP increased with amount of
polymer due to the progressive increase in repulsive forces
FIGURE 9. Cellular localization of pDNA in C6 cells. ELR polyplexes were formed with pDNA tagged with YOYO and ELR at (w/w) ratio of 80/1
and incubated with C6 cells for 3 h. YOYO-tagged DNA appears green and the nucleus is blue as a result of Hoechst stain. Cells visualized by
inverted fluorescence microscopy. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 10. Luciferase expression for different polyplex treatments.
C6 cells were transfected with ELR/pDNA poliplexes at an 80/1 weight
ratio. Luciferase activity was evaluated 48 h post-transfection and
expressed in RLU/lg protein lysate. pDNA was used as negative con-
trol. The results are expressed in logarithmic scale as mean6 stan-
dard error of three independent experiments. **p< 0.05.
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inside the polyplex favored by the presence of the hydro-
philic CPP. The stability of many colloidal systems is
directed related to the magnitude of their zeta potential.
Thus, if the value of the z-potential from the particle is high
(around 130 mV), the colloidal system will usually be sta-
ble. In contrast, if this value is around 0 mV the system will
tend to agglomerate. The resulting z-potential of the ELR-
pDNA polyplexes was up to 123.5 mV (Table IV). The posi-
tive z-potential suggests the distribution of positive charges
from the polymer on the periphery of the polyplexes. A pos-
itive z-potential is thought to improve cellular internaliza-
tion as a result of interaction with the negatively charged
plasmatic membrane.12
After these analysis, ELR-pDNA weight ratios of 80/1
and 120/1 showed the best physical characteristics for
transfection in in vitro assays. Initially the expression and
localization of plasmid DNA containing the p53 gene was
evaluated by confocal ﬂuorescence and quantiﬁed by the
luciferase system.
The expression of p53 gene was evaluated by a Live and
Dead assay where cells were incubated with the ELR-pDNA
polyplexes (Fig. 8). The maximum polymer concentration
reached was 300 mg/mL, which corresponds to the highest
ratio (120/1). At this concentration, according to the cyto-
toxicity assays, the cell viability for ELRs was 100%, thereby
suggesting that cell death is mainly due to the effect of the
p53 gene transfected into C6 glioma cells. The results
showed the higher cellular death in cells treated with LAE-
LIK120CPP polyplexes in contrast to the IMID-IK120.
Thereby, suggesting that the role of the LAEL fusogenic pep-
tide is essential to endosome escape by the polyplex rather
than the sponge effect mediated by the imidazole groups.
Interestingly, when incubated at a weight ratio of 2/1, PEI
induced a high level of cell death. One likely explanation for
this effect given the previously reported cytotoxic effects of
PEI is that cell death, after transfection with PEI at these
conditions, was probably due further by the p53 transgene
expression but also in lesser extent by the polymer itself.
Fluorescence microscopy was also use to localize the poly-
plexes once transfected into C6 cells (Fig. 9). The natural abil-
ity of penetratin to cross the plasmatic membrane and
facilitate the intracellular delivery of macromolecules by
either direct translocation or the endosomal or macropinocy-
tosis pathways is well known.57–59 In this assay, penetratin
favored the presence of the plasmid in the cytoplasm and
even inside the nucleus in cells transfected with the IKCPP-
pDNA polyplexes. However, in the case of polyplexes contain-
ing LAELIK120CPP, penetratin also triggered their internaliza-
tion but the LAEL peptide seemed to facilitate the
destabilization of the endosome membrane and the escape of
the pDNA into the cytoplasm, where it was extensively
located after the ﬁrst 3 h of incubation. Similarly, the imidaz-
ole groups in IMID-IK120 promoted the leakage of pDNA
from the endosome. Histidinylated oligo(ethanamino)amides
have recently been found to have enhanced transfection prop-
erties mediated by their increased buffering capacity at endo-
somal pH.60 The known “proton sponge effect”10 appeared to
boost some cytoplasmic and even nuclear presence of the
plasmid. The widespread location of the polyplexes containing
LAELIK120CPP at a ratio of 80/1 in the ﬁrst 3 h, and the
high expression of p53 gene after 48 h, suggest a slower but
more efﬁcient endosomal mechanism of escape governed by
the LAEL peptide than for imidazole groups.
Finally, the quantiﬁcation of transfection by the poly-
plexes was necessary for the direct application of these
ELRs in gene therapy (Fig. 10). The incorporation of func-
tional internalization peptides to lysine enriched ELR were
necessary for higher transfection efﬁciency levels. Indeed,
polyplexes containing the LAELIK120CPP polymer exhibited
the highest luciferase expression with more than ﬁvefold
than pDNA. Once the polyplexes are inside the endosome,
LAEL seems to play a key role in leakage of the pDNA from
the endosome. After incubation for 5 h, the luciferase pDNA
delivered by LAELIK120CPP was able to reach the nucleus.
In contrast, the main role of penetratin appears to be during
cell entry and it is not as important as regards endosomal
escape even though some plasmid still reaches the nucleus.
Additionally, LAEL seems to promote slower but more efﬁ-
cient outﬂow of the imidazole groups bound to the lysine-
rich polymer. Hence, LAEL plays a more relevant role in
transfection than CPP alone and incorporation of imidazole
groups. Lower transfection efﬁciency for ELRs was found
when comparing with PEI due to their lower charge density
that may give to the ELRs more compatible features. Similar
results of transfection had been previously reported for
ELRs appended with oligo-lysine or p [Asp(DET)]53 in com-
parison with BPEI,61,62 where despite of its toxicity, PEI was
also selected to compare luciferase expression levels due to
its good transfection properties.63,64 Taking together, the
previous research of ELR as nonviral vectors showed higher
toxicity than the ELRs developed in this work, with a viabil-
ity up to 70% for the oligo-lysine modiﬁed ELR and from
80% for p [Asp(DET)]53. The ﬁrst was formed by an ELR-
based diblock bearing an oligo-lysine for pDNA condensa-
tion. The second was constituted by an ELR-based diblock
containing diethylenetriamine (DET) modiﬁed poly-L-aspar-
tic acid segment which conferred less toxicity. Herein we
report cationic and highly biocompatible ELRs with acquired
functionalities able to condense and transfer genetic mate-
rial by themselves which represents a breakthrough in this
regard. In light to the results in biocompatibility, extensively
future experiments are warranted focusing in increasing the
charge density of the polyplexes in order to get similar
results than others polymers such as PEI together with in
vivo evaluation of the transfection.
CONCLUSION
We have designed, constructed, produced, and tested novel
and highly biocompatible ELR materials with different func-
tionalities for gene-delivery applications. Unlike other poly-
meric systems such as PEI or virus-derived vectors, these
ELRs possess a marked potential for protein modiﬁcations
by recombinant techniques in a totally controlled manner.
Notably, the analyzed ELRs exhibited high levels of viability
in vitro which is a striking contrast to PEI cytotoxicity.
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Indeed, incorporation of acquired functionalities provided
by the CPP, LAEL peptides, or protonable imidazole groups
provided higher levels of internalization and gene expres-
sion in comparison with the polyplexes formed either by
the nonmodiﬁed ELR or pDNA. All the ELR-pDNA polyplexes
studied showed cellular entry, with this being higher in the
case of LAELIK120CPP complexes. Penetratin plays a role in
the ﬁrst step of the internalization process, namely cellular
entry of the polyplexes, whereas LAEL and imidazole groups
to a lesser extent governed endosomal escape of the pDNA
via their fusogenic activity and proton sponge effect, respec-
tively. Future studies will be focused on improving the
transfection efﬁciency of these systems, due to their high
cytocompatibility and versatility, thus endowing them with
great potential in gene-therapy applications.
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